SC
TARO

Steven Cohen’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Steven Cohen’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,900
Closed -$1.61M – 1215
2021
Q1 		$1.61M Sell
21,900
-20,100
-48% -$1.53M 0.01% 757
2020
Q4 		$3.08M Buy
+42,000
New +$2.7M 0.02% 666

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Steven Cohen's TARO Position: Q2 2021 in Review

Steven Cohen sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2021, closing a stake of 21,900 shares — an estimated $1.61M sold.

Steven Cohen first reported a position in TARO in Q4 2020 and held it in 2 quarters. The position peaked at $3.08M in Q4 2020. 76 funds tracked by Wall St. Rank hold TARO as of Q2 2021.

  • Steven Cohen reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2021 after selling out during the quarter.
  • Steven Cohen sold 21,900 Taro Pharmaceutical Industries Ltd. shares in Q2 2021, an estimated $1.61M.
  • Steven Cohen first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2020 and held it in 2 quarters.
  • Steven Cohen's Taro Pharmaceutical Industries Ltd. position peaked at $3.08M in Q4 2020.
  • 76 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2021.

Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.